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Effects of Regional Versus General Anesthesia on
Outcomes After Total Hip Arthroplasty
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Investigation performed at the Washington University in St. Louis School of Medicine, St. Louis, Missouri
Background: Many orthopaedic surgical procedures can be performed with either regional or general anesthesia. We
hypothesized that total hip arthroplasty with regional anesthesia is associated with less postoperative morbidity and
mortality than total hip arthroplasty with general anesthesia.
Methods: This retrospective propensity-matched cohort study utilizing the American College of Surgeons National Surgical
Quality Improvement Program (ACS NSQIP) database included patients who had undergone total hip arthroplasty from 2007
through 2011. After matching, logistic regression was used to determine the association between the type of anesthesia and
deep surgical site infections, hospital length of stay, thirty-day mortality, and cardiovascular and pulmonary complications.
Results: Of 12,929 surgical procedures, 5103 (39.5%) were performed with regional anesthesia. The adjusted odds for
deep surgical site infections were signiﬁcantly lower in the regional anesthesia group than in the general anesthesia group
(odds ratio [OR] = 0.38; 95% conﬁdence interval [CI] = 0.20 to 0.72; p < 0.01). The hospital length of stay (geometric mean)
was decreased by 5% (95% CI = 3% to 7%; p < 0.001) with regional anesthesia, which translates to 0.17 day for each total
hip arthroplasty. Regional anesthesia was also associated with a 27% decrease in the odds of prolonged hospitalization (OR =
0.73; 95% CI = 0.68 to 0.89; p < 0.001). The mortality rate was not signiﬁcantly lower with regional anesthesia (OR = 0.78;
95% CI = 0.43 to 1.42; p > 0.05). The adjusted odds for cardiovascular complications (OR = 0.61; 95% CI = 0.44 to 0.85) and
respiratory complications (OR = 0.51; 95% CI = 0.33 to 0.81) were all lower in the regional anesthesia group.
Conclusions: Compared with general anesthesia, regional anesthesia for total hip arthroplasty was associated with a
reduction in deep surgical site infection rates, hospital length of stay, and rates of postoperative cardiovascular and
pulmonary complications. These ﬁndings could have an important medical and economic impact on health-care practice.
Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
T
otal hip arthroplasty is a common and effective treat-
ment for end-stage hip osteoarthritis. More than 200,000
primary total hip replacements and 36,000 revisions are
performed each year in the United States1.
Complications following total hip arthroplasty are rare,
with the rate of any major thirty-day complication commonly
reported to be 0.2% to 1.2%. Studies have suggested that older
age and a worse American Society of Anesthesiologists (ASA)
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physical status classiﬁcation2 as well as cardiovascular disease,
pulmonary disease, and diabetes are associated with higher
risks of death and postoperative complications3-5. Total hip
arthroplasty is performed either with regional anesthesia,
typically spinal anesthesia, or with general anesthesia, de-
pending on the discretion of the anesthesiology team, surgeon
preference, and patient choice. There is a lack of robust evi-
dence regarding postoperative outcomes to inform the choice
of anesthetic technique. Regional anesthesia has been hy-
pothesized to decrease postoperative complications by reduc-
ing sympathetic activation and inﬂammation, by preventing
venous stasis, and by avoiding tracheal intubation and positive
pressure ventilation6-8. However, to our knowledge, the inﬂu-
ence of anesthesia type on clinical outcomes has not been
studied with large clinical trials, and the investigations that have
been done have produced conﬂicting results9-11. In 2006,
Mauermann et al. performed a meta-analysis of studies carried
out from 1966 to 2005 and found lower rates of deep vein
thrombosis and pulmonary embolism following total hip ar-
throplasties done with regional anesthesia compared with those
done with general anesthesia12. They found no difference in
transfusion requirements between the groups12, whereas other
studies showed blood transfusion requirements to be lower
with regional anesthesia13. Most of these positive studies were
conducted years ago and may not reﬂect current practice. Over
the last two decades, anesthesia care, surgical techniques, and
postoperative care have improved, resulting in decreased peri-
operative morbidity and mortality despite increasing patient
age and comorbidities14,15. While several recent studies utilizing
large databases have suggested that regional anesthesia is su-
perior for hip fracture surgical procedures, we are aware of only
two studies of elective total hip arthroplasty that suggested that
regional anesthesia (spinal or epidural) might be associated
with lower rates of in-hospital complications and ninety-day
mortality5,16.
Minimizing complications of total hip arthroplasty is
an important public health concern. Despite the mounting
evidence that regional anesthesia might be associated with
improved outcomes, current American College of Surgeons
National Surgical Quality Improvement Program (ACS NSQIP)
data show that general anesthesia is still chosen for the majority
of total hip arthroplasties. We therefore conducted a propensity-
matched analysis to test the hypothesis that use of regional an-
esthesia decreases deep surgical site infection rates, hospital
length of stay, postoperative mortality, and rates of cardiovas-
cular and respiratory complications compared with general
anesthesia in patients treated with total hip arthroplasty.
Materials and Methods
The ACS NSQIP is conducted under institutional review board approval atBarnes-Jewish Hospital, Washington University in St. Louis. The present study
was performed with use of the preexisting and deidentiﬁed Participant Use Data File
and thus was exempt from further review. The STROBE (Strengthening the Re-
porting of Observational Studies in Epidemiology) checklist for observational studies
was used to guide the methods of this study and to structure this manuscript
17
.
We conducted a retrospective cohort study with prospectively collected
data on adults undergoing elective total hip replacement from January 1, 2007,
through December 31, 2011, who were part of the ACS NSQIP. The purpose of
the ACS NSQIP is to provide risk-adjusted clinical outcome data to partici-
pating hospitals to drive effective quality improvement. The database consists
of 135 perioperative variables and thirty-day postoperative morbidity and
mortality outcomes for patients treated with non-cardiac surgery.
Dedicated data personnel collect, validate, and submit the data at each site
after rigorous uniform training and examination. Per ACS NSQIP guidelines, all
variables, including complications, have predeﬁned deﬁnitions and speciﬁcations
(http://site.acsnsqip.org). During the submission of data from each institution,
user information prompts are implemented to ensure completeness, uniformity,
and validity of the data. Data integrity measures, including site visits, conference
calls, an annual meeting of participants, interrater reliability site visits, and au-
diting, are regularly performed to safeguard the reliability and validity of the
system’s data. Several studies have demonstrated the high quality and validity of
the ACS NSQIP database
18
; the combined results of audits revealed an overall
disagreement rate of approximately 1.8% for all variables.
At the end of the calendar year 2011, 316 hospitals were included in the data
set; 49% of themwere classiﬁed as “academic/teaching” and 51%, as “non-teaching.”
There were three types of participation in this study period: classic, targeted, and
essential. Classic programs have the least missing data on baseline characteristics of
interest, so they were included for the analysis in this study (see details below).
Inclusion and Exclusion Criteria
We queried the ACS NSQIP database using Current Procedural Terminology
(CPT) codes for primary total hip replacement (CPT 27130) and conversions to
or revisions of total hip arthroplasties (CPT 27132, 27134, 27137, and 27138).
All patients who received any regional anesthesia (spinal or epidural) or general
anesthesia for primary or revision total hip arthroplasty in the classic programs
were included. Demographic data, comorbidities, medical history, and surgical
characteristics, including the type of procedure performed, were obtained for
all identiﬁed patients. Case exclusion criteria were cases from non-classic
programs as those programs had not collected data on ten of the thirty-two
baseline variables, an age under sixteen years, preoperative mechanical venti-
lation as regional anesthesia is not an option when mechanical ventilation is
used, preoperative coma, and no report of the type of anesthesia or use of a type
other than spinal, epidural, or general anesthesia (Fig. 1).
Outcomes and Interpretation
Outcomes of interest were deep surgical site infectionwithin thirty days after surgery
and hospital length of stay from the day of the surgery until discharge. Hospital
length of stay was used as a continuous variable, and it was also used as a categorical
variable—i.e., prolonged hospital length of stay (yes or no), deﬁned as longer than
the average plus two standard deviations (SD) of the mean. Furthermore, the
mortality rate as well as the rates of cardiovascular and pulmonary complications
within thirty days after surgery were assessed. Cardiovascular complications and
pulmonary complications were composite outcomes of other ACS NSQIP-deﬁned
events. A cardiovascular complication was deﬁned as the occurrence of myocardial
infarction, stroke, deep venous thrombosis, or pulmonary embolism. A pulmonary
complication was deﬁned as the occurrence of pneumonia or respiratory failure
requiring intubation as speciﬁed within ACS NSQIP.
Statistical Analysis
Demographic and clinical characteristics were compared between the regional
and general anesthesia groups by using Pearson chi-square tests for all
categorical variables. Possible selection bias was addressed by performing
propensity score matching. The propensity score for each individual is deﬁned
as the probability of receiving the treatment (regional anesthesia) given the
patient’s baseline characteristics and comorbidities (Table I). This incorporated
thirty-two variables, including demographic variables and comorbidities (some
of the thirty-two variables were combined to obtain a total of twenty-ﬁve
baseline variables used for matching).
Multiple matching models with different matching ratios and calipers
were evaluated to select a matching model with the overall best balance and the
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smallest reduction in the number of treated patients (regional anesthesia
group). Nearest-neighbor matching with replacement with up to two controls
(general anesthesia group) for each treated patient (regional anesthesia group)
was used with a caliper of 0.05 SD of a patient’s predicted propensity score.
Nearest-neighbor matching selects, for each treated individual i, the control
individual with the smallest distance in propensity score from individual i. To
account for the fact that some treated cases could be matched to only one
control or one control could be used multiple times, weights were generated to
correct for this disproportion. Every treated patient received a weight of one,
and the weights for the matched control units were calculated by ntreatedi/
ncontroli, where ntreatedi and ncontroli were the number of treated and control units
in stratum i. The control group weights were then scaled to sum to the number
of uniquely matched control units. Following propensity score matching, the
balance of the matched treated and control groups was evaluated by calculating
variance ratios and absolute values of the standardized differences in means as
well as by performing the Hotelling test, which is a generalization of the Student
t statistic used in multivariate hypothesis testing
19-21
.
Unadjusted analyses were conducted for all outcomes before and after
propensity score matching. To depict the inﬂuence of propensity score matching
on the differences in outcomes, the t test and chi-square test were used before
matching; the weighted t test and chi-square test were used after matching as
deemed appropriate. Hospital length of stay was analyzed as a continuous out-
come and as a binary outcome as prolonged hospital length of stay (a stay longer
than the geometric mean 1 [2 · SD]). Because hospital length of stay was not
normally distributed but rather was skewed to the right, a lognormal transfor-
mation was conducted to create a more normal distribution. Geometric means
with standard deviations were calculated for both groups. Comparisons were
conducted by using aweighted t test on the lognormal transformed length of stay,
and the geometric mean ratio was examined as an effect size estimate
22,23
. Pro-
longed hospital length of stay was analyzed by performing a chi-square test before
matching and a weighted chi-square test after matching.
To further evaluate the potential effects of anesthesia type on outcome
variables, multivariable analyses were conducted after propensity matching to
adjust for speciﬁc covariates. Those covariates were deﬁned a priori on the basis
of clinical relevance reported in previous studies
3,24
. The number of covariates
per logistic regressionmodel was restricted to at least ten events per covariate to
decrease the likelihood of overﬁtting.
As an age of greater than ninety years was not reported as a continuous
variable in the ACS NSQIP data, we categorized age into three groups with
comparable sizes.
Conditional multivariable logistic regression was used to evaluate the
association between the type of anesthesia and deep surgical site infection,
thirty-day mortality, and cardiovascular and pulmonary complications by using
data from the matched patient cohort. A proportional hazard Cox regression
analysis was performed to determine whether regional or general anesthesia
had a signiﬁcant inﬂuence on hospital length of stay.
Goodness of ﬁt for the logistic regression was assessed with the log
likelihood ratio and the Wald and Hosmer-Lemeshow tests. For the propor-
tional hazards Cox regression, we checked the proportionality of hazards by
testing for non-zero slopes in a generalized linear regression of the scaled
Schoenfeld residuals on functions of time, and additionally graphically by eye. A
p value of <0.05 was considered signiﬁcant in all applied tests. As the type of
procedure (that is, primary or revision) may affect the anesthesia type selection,
an interaction term was included in the regression models but was removed
later as it was not signiﬁcant. SPSS software (version 21; IBM, Armonk, New
York) was used for data handling, and R (version 2.15.3; Institute of Statistics
and Mathematics, R Foundation of Statistical Computing) with the packages




There was no external funding source for this study.
Results
From 2007 to 2011, 20,606 total hip arthroplasties were in-cluded in the NSQIP registry. Of these, 12,929 were from
Fig. 1
Schematic demonstration of study sample. ACS NSQIP = American College of Surgeons National Surgical Quality Improvement Program, CPT = Current
Procedural Terminology, and THA = total hip arthroplasty.
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TABLE I Characteristics of Patients Receiving Regional or General Anesthesia
ACS NSQIP-Speciﬁed Factors




(N = 5103 [39.5%])
General* (N = 7826
[60.5%]) (no. [%]) P Value
Type of total hip replacement 0.001 0.85
Primary 4583 (89.8) 6331 (80.9)
Revision 520 (10.2) 1495 (19.1)
Demographic characteristics
Age 0.001 0.28
£60 yr 1674 (32.8) 2807 (35.9)
61-70 yr 1545 (30.3) 2289 (29.2)
>70 yr 1884 (36.9) 2730 (34.9)
Sex 0.086 0.61
Female 2865 (56.1) 4273 (54.6)
Male 2238 (43.9) 3553 (45.4)
Race/ethnicity 0.001 0.31
White 3916 (76.7) 6527 (83.4)
Other 1187 (23.3) 1299 (16.6)
Preoperative health and comorbidities
Body mass index 0.001 0.81
<30 kg/m2 3042 (59.6) 4425 (56.5)
30-40 kg/m2 1756 (34.4) 2806 (35.9)
>40 kg/m2 305 (6) 595 (7.6)
Hypertension (on medication) 2990 (58.6) 4627 (59.1) 0.560 0.58
Diabetes mellitus 0.041 0.16
Type II 471 (9.2) 696 (8.9)
Type I 126 (2.5) 252 (3.2)
Chronic obstructive pulmonary disease 240 (4.7) 361 (4.6) 0.832 0.48
Congestive heart failure symptoms within 1 mo 8 (0.2) 32 (0.4) 0.016 0.80
Myocardial infarction within 6 mo or angina within 1 mo 28 (0.5) 55 (0.7) 0.312 0.89
Revascularization (angioplasty or coronary artery bypass graft) 458 (9) 798 (10.2) 0.023 0.56
Peripheral vascular disease 33 (0.6) 80 (1.0) 0.027 0.71
History of stroke or transient ischemic attack 256 (5) 461 (5.9) 0.034 0.75
Dialysis 7 (0.1) 34 (0.4) 0.004 1.0
Steroid use 154 (3) 325 (4.2) 0.001 0.60
Systemic inﬂammatory response syndrome or sepsis preoperatively 33 (0.6) 108 (1.4) 0.001 0.72
Bleeding disorder 100 (2) 340 (4.3) 0.001 0.89
Transfusion: >4 units in 72 hr before surgery 13 (0.3) 40 (0.5) 0.036 1.0
Disseminated cancer 19 (0.4) 47 (0.6) 0.080 0.65
Chemotherapy or radiation therapy 18 (0.4) 29 (0.4) 0.996 0.87
ASA classiﬁcation† 0.001 0.69
1 or 2 2971 (58.2) 4058 (51.9)
3 or 4 2131 (41.8) 3768 (48.1)
Contaminated surgical site 254 (5) 331 (4.2) 0.046 0.82
>10% loss of body weight in last 6 mo 19 (0.4) 49 (0.6) 0.063 0.40
Functional status: dependent 427 (8.4) 630 (8.1) 0.533 0.89
Dyspnea on exertion or at rest 355 (7.0) 616 (7.9) 0.056 0.73
*The values are given as the number of patients with the percentage in parentheses. †One of the 5103 cases was not matched (used in the analysis).
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classic programs with no missing perioperative variables of in-
terest (Fig. 1). There were 10,914 primary hip arthroplasties
(84.4%) and 2015 revision procedures (15.6%). Regional anes-
thesia was used for 5103 (39.5%) of the procedures, and general
anesthesia was used for 7826 (60.5%). The regional anesthesia
was spinal in 4377 (85.8%) of the cases, epidural in 126 (2.5%),
and “unspeciﬁed regional” in the remaining 600 (11.8%). The
rate of regional anesthesia in the non-classic programs was 39.1%,
and the rate of general anesthesia was 60.9%.
Before propensity score matching, sixteen of the twenty-
ﬁve baseline factors differed signiﬁcantly between the two an-
esthesia groups. There were no signiﬁcant differences between
the groups after 1:2 matching and use of a caliper of 0.05 (Table
I). All regional anesthesia cases except one (5102 cases) were
matched to 5396 general anesthesia cases.
Deep surgical site infections were signiﬁcantly less
common after regional anesthesia than after general anesthesia
(0.22% compared with 0.57%), with an odds ratio (after
matching) of 0.38 (95% conﬁdence interval [CI] = 0.20 to 0.72;
p < 0.01). Deep surgical site infections were also associated
with revision arthroplasties, age, and insulin-dependent dia-
betes (Tables II and III).
The unadjusted average hospital length of stay, after
matching, was shorter after regional anesthesia (geometric mean
and SD, 3.2 ± 1.6 days) than after general anesthesia (geometric
mean, 3.4 ± 1.6 days). Proportionally, this yields an odds ratio
(OR) for length of stay of 0.95 (95%CI= 0.93 to 0.97) for regional
anesthesia with a mean difference (compared with general anes-
thesia) of 0.05 (95%CI= 0.03 to 0.07; p < 0.001), which translates
to 0.17 day for each total hip arthroplasty (Table II).
The adjusted odds of the hospital length of stay were 8%
lower in the regional anesthesia group (OR = 0.92; 95% CI =
0.89 to 0.94; p < 0.001) (see Appendix). Figure 2 shows con-
sistent earlier discharge (shorter hospital length of stay) in the
regional anesthesia group compared with the general anes-
thesia group. The odds of a patient having a prolonged hospital
length of stay, after we controlled for other factors, was 24%
lower in the regional anesthesia group: 5% compared with
6.6% in the general anesthesia group (OR = 0.73; 95% CI =
0.68 to 0.89; p < 0.001).
Thirty-day mortality was a rare event, with an after-
matching prevalence of 0.29% in the regional anesthesia group
and 0.37% in the general anesthesia group (Table II). In the
multivariable analysis, the mortality odds were not signiﬁcantly
lower in the regional anesthesia group (OR = 0.78; 95%CI = 0.43
TABLE II Unadjusted Outcomes of Regional Versus General Anesthesia Before and After Propensity Score Matching














Deep surgical site infection 11 (0.2) 61 (0.8) 0.27 (0.1-0.5);
p < 0.001
11 (0.22) 30.6 (0.57) 0.38 (0.2-0.7);
p < 0.01
Hospital length of stay (days) 3.19 ± 1.61 3.37 ± 1.62 0.95† (0.93-0.96);
p < 0.001
3.19 ± 1.61 3.35 ± 1.62 0.95‡ (0.93-0.97);
p < 0.001
Prolonged hospital length of stay§ 256 (5.0) 556 (7.1) 0.7 (0.6-0.8);
p < 0.001
256 (5) 354 (6.6) 0·75 (0.64-0.89);
p < 0.01
Mortality 15 (0.3) 39 (0.5) 0.59 (0.3-1.1) 15 (0.29) 20.1 (0.37) 0.78 (0.4-1.4)
Cardiovascular complications 44 (0.9) 121 (1.5) 0.55 (0.4-0.8);
p < 0.001
44 (0.86) 75.6 (1.40) 0.61 (0.4-0.9);
p < 0.01
Respiratory complications 23 (0.5) 85 (1.1) 0.41 (0.3-0.7);
p < 0.001
23 (0.45) 47.1 (0.87) 0.51 (0.3-0.8);
p < 0.01
*The values are given as the number of patients with the percentage in parentheses, except for the hospital length of stay, which is given as the geometric
mean and standard deviation in days. †Geometric mean ratio = 6% (95% CI = 4% to 8%). ‡Geometric mean ratio = 5% (95% CI = 3% to 7%). §Prolonged
hospital length of stay is deﬁned as longer than the average plus two standard deviations (seven days or longer).
Fig. 2
Kaplan-Meier survival curves showing adjusted cumulative hazard of
hospital discharge comparing regional anesthesia to general anesthesia.
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to 1.42; p > 0.05) (Fig. 3). Factors that were signiﬁcantly asso-
ciated with increased postoperative mortality were revision total
hip arthroplasty (OR= 2.24; 95% CI = 1.12 to 4.48; p < 0.05), an
age of more than seventy years compared with an age of less than
ﬁfty years (OR= 5.94; 95%CI= 2.06 to 17.1; p < 0.01), ASA class
3 or 4 compared with ASA class 1 or 2 (OR= 2.24; 95%CI= 1.15
to 4.36; p < 0.05), and insulin-dependent diabetes compared with
no diabetes (OR = 3.10; 95% CI = 1.1 to 9.02; p < 0.05).
The adjusted odds for cardiovascular complications (OR=
0.61; 95% CI = 0.44 to 0.85) and respiratory complications
TABLE III Results of Multivariable Logistic Regression Analyses for Deep Surgical Site Infection, Mortality, and Respiratory Complications
OR (95% CI); P Value
Factor Deep Surgical Site Infection Mortality Respiratory Complications
Regional anesthesia 0.38 (0.2-0.7); p < 0.01 0.78 (0.4-1.4) 0.51 (0.3-0.8); p < 0.01
Revision total hip arthroplasty 3.11 (1.8-5.3); p < 0.001 2.24 (1.1-4.5); p < 0.05 1.94 (1.2-3.1); p < 0.01
Age
£60 yr Reference Reference Reference
61-70 yr 3.40 (1.7-6.8); p < 0.01 1.07 (0.3-4.3) 1.66 (0.8-3.3)
>70 yr 2.29 (1.2-4.6); p < 0.01 5.94 (2.1-17.1); p < 0.01 3.34 (1.8-6.1); p < 0.001
ASA class 3 or 4 1.33 (0.8-2.3) 2.24 (1.2-4.4); p < 0.05 4.68 (2.4-7.7); p < 0.001
Diabetes mellitus
No Reference Reference Reference
Non-insulin dependent 0.76 (0.3-2.1) 0.51 (0.1-2.1) 0.93 (0.5-1.8)
Insulin-dependent 3.27 (1.4-7.9); p < 0.05 3.10 (1.1-9.0); p < 0.05 4.27 (2.4-7.7); p < 0.001
Fig. 3
Logistic regression analysis result for outcomes comparing regional anesthesia with general anesthesia after propensity score matching. The diamonds
indicate the odds ratios, which show a decreased odds for each outcomewith regional anesthesia, and the lines through the diamonds indicate the 95%CI.
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(OR = 0.51; 95% CI = 0.33 to 0.81) were all lower with regional
anesthesia (Fig. 3).
Other important factors affecting the outcomes are sum-
marized in Table III and a table in the Appendix.
Discussion
Using the ACS NSQIP database and a propensity-matchedanalysis, we studied the impact of anesthesia type on thirty-
day outcomes following total hip arthroplasty. Compared with
general anesthesia, regional anesthesia was associated with im-
pressive reductions in postoperative deep surgical site infection
rates, hospital length of stay, and rates of cardiovascular and
pulmonary complications. Regional anesthesia was associated
with a nonsigniﬁcant 0.2% decrease in mortality. As mortality in
the thirty days following total hip arthroplasty is rare, and the
possible decrease in mortality attributable to regional anesthesia
is low, a very large study would be needed in order to detect a
mortality beneﬁt attributable to regional anesthesia.
The severity of comorbidities as well as the duration of
surgery, the length of the preoperative hospital stay, and low
hospital volume have been identiﬁed as risk factors for deep
surgical site infection following total hip replacement27. Pre-
ventive measures such as timely administration of antibiotics,
maintenance of normothermia, and minimizing transfusions
are well known28, but previous reports did not show regional
anesthesia to have as important an effect on deep surgical site
infections after total hip or knee replacement29,30. Possible
mechanisms for how regional anesthesia lowers the prevalence
of deep surgical site infection might be alterations in immune
response31 and sympathetic blocking effects with concomitant
vasodilation improving tissue perfusion and oxygenation32.
Hospital length of stay is often used as a proxy for post-
operative complications and resource utilization33. The study of
prolonged hospital stay or length-of-stay outliers is essential for
the management and ﬁnancing of hospitals. We chose to deﬁne
a prolonged length of stay as the geometric mean plus two
standard deviations as this approach was superior to three
others in predicting cost34. Regional anesthesia was associated
with decreases in all measures related to length of stay. Given
that total hip arthroplasty is such a common surgical procedure,
even aminor decrease in hospital length of stay could havemajor
resource-savings implications.
Previous studies comparing regional anesthesia and gen-
eral anesthesia have demonstrated conﬂicting results. Some
studies have not shown beneﬁts9,10, while others have demon-
strated decreased blood loss, fewer respiratory complications,
and a lower risk of thromboembolism with regional anesthe-
sia11,35,36. In a recent retrospective analysis from the National Joint
Registry for England and Wales of ninety-day mortality after
total hip replacement, spinal anesthesia, but not epidural anes-
thesia, was associated with a lower mortality rate5. The limita-
tions of some of these studies as guides for current standards of
care include relatively low patient numbers and changes in
perioperative practice since the collection of the data. Mem-
tsoudis and colleagues reported similar results concerning pul-
monary, cardiac, and infectious complications in a large data set
of patients who underwent total hip or knee arthroplasty under
regional or general anesthesia37. That study had potential
limitations; the database was administrative rather than
medical, 27% of the cases had missing data on anesthesia type,
a high percentage of patients received combined regional and
general anesthesia, and the reported complication rates were
in-hospital.
The credibility and general applicability of the main
ﬁndings of our study are supported by several factors. First, the
results are based on a recent, prospectively collected, multi-
center data set of patients who underwent primary or revision
total hip arthroplasty at a wide range of hospitals in both
the private and the academic sector. Second, we utilized a
propensity-score-matching technique in an attempt to balance
factors affecting the exposure and regression models to con-
trol for confounders affecting the outcome. Third, the esti-
mated prevalences of each of the individual complications
included in the composite outcomes were consistently lower
for patients who received regional anesthesia, suggesting ben-
eﬁt across complications. Fourth, the results are biologically
plausible, as regional techniques and drugs block sympathetic
nerve activity, reduce cytokine production, and inhibit platelet
function7,8.
This study has important limitations. As it was not a
randomized controlled trial, despite statistical corrections,
unaccounted (unobserved) factors could have biased treat-
ment exposure (to regional or general anesthesia), and hidden
confounders might have biased the outcomes. For example,
there could have been location bias, as the proportion of each
anesthetic type might differ according to hospital center.
Quality of care in general is likely to vary among hospital
centers as well.
Another important limitation is that details about the
general anesthetics were not considered. The outcomes associ-
ated with general anesthesia with long-acting agents, inadequate
analgesia, hemodynamic shifts, and unnecessarily deep an-
esthesia might be very different from those associated with
“fast-track” general anesthesia with rapid and predictable
agents, multimodal analgesia, targeted hemodynamic control,
and appropriately titrated anesthetic depth. These aspects and
other unrecorded perioperative information (for example,
postoperative pain and delirium) could have biased the
outcomes.
In conclusion, although the ACS NSQIP utilizes a sys-
tematic sampling approach that is not guaranteed to provide
a perfect estimate of procedure-type prevalence across the
country, if the data observed here are reﬂective, then despite
emerging evidence regional anesthesia appears to have been
potentially underutilized during this study period (used for
only 40% of total hip arthroplasties). The results reported here
add credence to the notion that regional anesthesia is associated
with a reduction in deep surgical site infection rates, length of
hospital stay, and postoperative morbidity compared with
general anesthesia. These ﬁndings, if replicated in appropriately
designed effectiveness studies, could have an important med-
ical and economic impact on health-care practice.
192
THE JOURNAL OF BONE & JOINT SURGERY d J B J S .ORG
VOLUME 97-A d NUMBER 3 d FEBRUARY 4, 2015
EFFECTS OF REGIONAL VERSUS GENERAL ANESTHES IA ON OUTCOMES
AFTER TOTAL HIP ARTHROPLASTY
Appendix
A table showing the results of multivariable logistic re-
gression analyses for hospital length of stay and cardio-
vascular complications is available with the online version of
this article as a data supplement at jbjs.org. n
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